Meeting
2017 ASCO Annual Meeting
REsect: Blinded assessment of amenability to potentially curative treatment of previously unresectable colorectal cancer liver metastases (CRC LM) after chemotherapy ± RadioEmbolization (SIRT) in the randomized SIRFLOX trial.
Authors
Benjamin Garlipp
Otto-von-Guericke-University Hospital, Magdeburg, Germany
Benjamin Garlipp , Peter Gibbs , Guy A. Van Hazel , Rohan Jeyarajah , Robert C. G. Martin II, Christiane J. Bruns , Hauke Lang , Derek M. Manas , Giuseppe Maria Ettorre , Fernando Pardo , Vincent Donckier , Christoph Benckert , Thomas M van Gulik , Diane Goere , Michael Schoen , Johann Pratschke , Wolf O. Bechstein , Antonio Martínez de la Cuesta , Shola Adeyemi , Max Seidensticker
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Clinical Trial Registration Number
NCT00724503
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3532)
DOI
10.1200/JCO.2017.35.15_suppl.3532
Abstract #
3532
Poster Bd #
155
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
A randomized phase II study of perioperative chemotherapy plus bevacizumab versus postoperative chemotherapy plus bevacizumab inpatients with upfront resectable hepatic colorectal metastases (APPROACH).
First Author: You Jin Chun
Poster
2018 ASCO Annual Meeting
Outcomes of oxaliplatin-based (Ox) chemotherapy (CT) on R0 resection of colonic liver metastases (CLM).
First Author: Nicholas Adam Bosma
Poster
2013 ASCO Annual Meeting
Randomized, phase II study of bevacizumab with mFOLFOX6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: Resectability and safety in OLIVIA.
First Author: Thomas Gruenberger
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Preoperative chemotherapy prior to primary tumor resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: A multicenter randomized controlled trial.
First Author: Qi Lin